Cargando…

Functional KCa1.1 channels are crucial for regulating the proliferation, migration and differentiation of human primary skeletal myoblasts

Myoblasts are mononucleated precursors of myofibers; they persist in mature skeletal muscles for growth and regeneration post injury. During myotonic dystrophy type 1 (DM1), a complex autosomal-dominant neuromuscular disease, the differentiation of skeletal myoblasts into functional myotubes is impa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tajhya, Rajeev B, Hu, Xueyou, Tanner, Mark R, Huq, Redwan, Kongchan, Natee, Neilson, Joel R, Rodney, George G, Horrigan, Frank T, Timchenko, Lubov T, Beeton, Christine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133989/ https://www.ncbi.nlm.nih.gov/pubmed/27763639 http://dx.doi.org/10.1038/cddis.2016.324

Ejemplares similares

Different expression of β subunits of the KCa1.1 channel by invasive and non-invasive human fibroblast-like synoviocytes
por: Pethő, Zoltán, et al.
Publicado: (2016)

Erratum to: Different expression of β subunits of the KCa1.1 channel by invasive and non-invasive human fibroblast-like synoviocytes
por: Pethő, Zoltán, et al.
Publicado: (2016)

Blocking KCa3.1 Channels Increases Tumor Cell Killing by a Subpopulation of Human Natural Killer Lymphocytes
por: Koshy, Shyny, et al.
Publicado: (2013)

Development of Highly Selective Kv1.3-Blocking Peptides Based on the Sea Anemone Peptide ShK
por: Pennington, Michael W., et al.
Publicado: (2015)

KCa1.1 and Kv1.3 channels regulate the interactions between fibroblast-like synoviocytes and T lymphocytes during rheumatoid arthritis
por: Tanner, Mark R., et al.
Publicado: (2019)

A Potent and Selective Peptide Blocker of the Kv1.3 Channel: Prediction from Free-Energy Simulations and Experimental Confirmation
por: Rashid, M. Harunur, et al.
Publicado: (2013)

Quantitative Measurement of GLUT4 Translocation to the Plasma Membrane by Flow Cytometry
por: Koshy, Shyny, et al.
Publicado: (2010)

Low Voltage Activation of KCa1.1 Current by Cav3-KCa1.1 Complexes
por: Rehak, Renata, et al.
Publicado: (2013)

Contribution of the KCa3.1 channel–calmodulin interactions to the regulation of the KCa3.1 gating process
por: Morales, Patricia, et al.
Publicado: (2013)

Antigenic sites on the H(N) domain of botulinum neurotoxin A stimulate protective antibody responses against active toxin
por: Vijayalakshmi Ayyar, B., et al.
Publicado: (2015)

Correction of RNA-Binding Protein CUGBP1 and GSK3β Signaling as Therapeutic Approach for Congenital and Adult Myotonic Dystrophy Type 1
por: Timchenko, Lubov
Publicado: (2019)

Development of Therapeutic Approaches for Myotonic Dystrophies Type 1 and Type 2
por: Timchenko, Lubov
Publicado: (2022)

Preferential uptake of antioxidant carbon nanoparticles by T lymphocytes for immunomodulation
por: Huq, Redwan, et al.
Publicado: (2016)

A piggyBac-based reporter system for scalable in vitro and in vivo analysis of 3′ untranslated region-mediated gene regulation
por: Chaudhury, Arindam, et al.
Publicado: (2014)

Myotonic Dystrophies 1 and 2: Complex Diseases with Complex Mechanisms
por: Schoser, Benedikt, et al.
Publicado: (2010)

Distribution and kinetics of the Kv1.3-blocking peptide HsTX1[R14A] in experimental rats
por: Bergmann, Ralf, et al.
Publicado: (2017)

Recombinant Expression of Margatoxin and Agitoxin-2 in Pichia pastoris: An Efficient Method for Production of K(V)1.3 Channel Blockers
por: Anangi, Raveendra, et al.
Publicado: (2012)

Myoblast 3D bioprinting to burst in vitro skeletal muscle differentiation
por: Ronzoni, Flavio L., et al.
Publicado: (2022)

Detection of Functional Matrix Metalloproteinases by Zymography
por: Hu, Xueyou, et al.
Publicado: (2010)

A potent and Kv1.3-selective analogue of the scorpion toxin HsTX1 as a potential therapeutic for autoimmune diseases
por: Rashid, M. Harunur, et al.
Publicado: (2014)

GSK3β is a new therapeutic target for myotonic dystrophy type 1
por: Wei, Christina, et al.
Publicado: (2013)

The Dynamic and Crucial Role of the Arginine Methylproteome in Myoblast Cell Differentiation
por: Papanikolaou, Nikolaos A., et al.
Publicado: (2023)

CELF1 is a central node in post-transcriptional regulatory programmes underlying EMT
por: Chaudhury, Arindam, et al.
Publicado: (2016)

Novel Phenolic Inhibitors of Small/Intermediate-Conductance Ca(2+)-Activated K(+) Channels, KCa3.1 and KCa2.3
por: Oliván-Viguera, Aida, et al.
Publicado: (2013)

Investigating CFTR and KCa3.1 Protein/Protein Interactions
por: Klein, Hélène, et al.
Publicado: (2016)

Repurposing the KCa3.1 inhibitor senicapoc for Alzheimer's disease
por: Jin, Lee‐Way, et al.
Publicado: (2019)

KCa3.1 channels are involved in the infiltrative behavior of glioblastoma in vivo
por: D'Alessandro, G, et al.
Publicado: (2013)

Requirement for PINCH in skeletal myoblast differentiation
por: Liao, Huimin, et al.
Publicado: (2022)

Myotonic Dystrophy: From Molecular Pathogenesis to Therapeutics
por: Timchenko, Lubov
Publicado: (2022)

Characterization of the PCMBS-dependent modification of KCa3.1 channel gating
por: Bailey, Mark A., et al.
Publicado: (2010)

KCa3.1 Channel Modulators as Potential Therapeutic Compounds for Glioblastoma
por: Brown, Brandon M., et al.
Publicado: (2018)

Radiation Increases Functional KCa3.1 Expression and Invasiveness in Glioblastoma
por: D’Alessandro, Giuseppina, et al.
Publicado: (2019)

Modulation of Retrograde Trafficking of KCa3.1 in a Polarized Epithelium
por: Lee, Bob Shih-Liang, et al.
Publicado: (2017)

KCa3.1 Impairment Is Not Just a Slow Afterthought in Epilepsy
por: Gross, Christina
Publicado: (2020)

Histidine phosphorylation relieves copper inhibition in the mammalian potassium channel KCa3.1
por: Srivastava, Shekhar, et al.
Publicado: (2016)

Pim1 kinase positively regulates myoblast behaviors and skeletal muscle regeneration
por: Liu, Yuantong, et al.
Publicado: (2019)

Adhesion Proteins - An Impact on Skeletal Myoblast Differentiation
por: Przewoźniak, Marta, et al.
Publicado: (2013)

MiR-146a wild-type 3′ sequence identity is dispensable for proper innate immune function in vivo
por: Bertolet, Grant, et al.
Publicado: (2019)

KCa3.1 ion channel: A novel therapeutic target for corneal fibrosis
por: Anumanthan, Govindaraj, et al.
Publicado: (2018)

Therapeutic Targeting of the GSK3β-CUGBP1 Pathway in Myotonic Dystrophy
por: Lutz, Maggie, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4841kcucp5bc6tfhilnkfi68ur